These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9802924

  • 1. Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes.
    Levine JS, Subang R, Koh JS, Rauch J.
    J Autoimmun; 1998 Oct; 11(5):413-24. PubMed ID: 9802924
    [Abstract] [Full Text] [Related]

  • 2. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner.
    Price BE, Rauch J, Shia MA, Walsh MT, Lieberthal W, Gilligan HM, O'Laughlin T, Koh JS, Levine JS.
    J Immunol; 1996 Sep 01; 157(5):2201-8. PubMed ID: 8757347
    [Abstract] [Full Text] [Related]

  • 3. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.
    Subang R, Levine JS, Janoff AS, Davidson SM, Taraschi TF, Koike T, Minchey SR, Whiteside M, Tannenbaum M, Rauch J.
    J Autoimmun; 2000 Aug 01; 15(1):21-32. PubMed ID: 10936025
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiphospholipid antibodies mediate autoimmunity against dying cells.
    Andreoli L, Fredi M, Nalli C, Franceschini F, Meroni PL, Tincani A.
    Autoimmunity; 2013 Aug 01; 46(5):302-6. PubMed ID: 23713583
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies.
    Rovere P, Manfredi AA, Vallinoto C, Zimmermann VS, Fascio U, Balestrieri G, Ricciardi-Castagnoli P, Rugarli C, Tincani A, Sabbadini MG.
    J Autoimmun; 1998 Oct 01; 11(5):403-11. PubMed ID: 9802923
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies.
    Bordron A, Dueymes M, Levy Y, Jamin C, Ziporen L, Piette JC, Shoenfeld Y, Youinou P.
    Arthritis Rheum; 1998 Oct 01; 41(10):1738-47. PubMed ID: 9778215
    [Abstract] [Full Text] [Related]

  • 19. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J.
    Verh K Acad Geneeskd Belg; 2000 Oct 01; 62(5):353-72. PubMed ID: 11144685
    [Abstract] [Full Text] [Related]

  • 20. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E, Glidden DV, Elder ME.
    Arthritis Rheum; 2002 Aug 01; 47(4):414-20. PubMed ID: 12209489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.